News
AstraZeneca has axed three MedImmune legacy monoclonal antibody drugs from its neuroscience pipeline in a first quarter clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback